Comparison of pharmacokinetics of lanoteplase and alteplase during acute myocardial infarction (Q74326637)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12074692%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

title

Comparison of pharmacokinetics of lanoteplase and alteplase during acute myocardial infarction (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12074692%20AND%20SRC:MED&resulttype=core&format=json

acute myocardial infarction

10 November 2019

main subject

1 reference

1 reference

John B Kostis

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12074692%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Randy C Dockens

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12074692%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Udho Thadani

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12074692%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Vasnath Bethala

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12074692%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Carl Pepine

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12074692%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Wayne Leimbach

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12074692%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Nimish Vachharajani

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12074692%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Ralph H Raymond

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12074692%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Bruce C Stouffer

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12074692%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Lee K Tay

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12074692%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Wen Chyi Shyu

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12074692%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Wei-chi Liao

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12074692%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

publication date

1 January 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12074692%20AND%20SRC:MED&resulttype=core&format=json

Clinical Pharmacokinetics

10 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12074692%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

volume

41

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12074692%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12074692%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

page(s)

445-452

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12074692%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.2165/00003088-200241060-00005

10 November 2019

exact match

0 references

cites work

Pharmacokinetic and hemostatic properties of the recombinant plasminogen activator bm 06.022 in healthy volunteers

1 reference

12 December 2020

Pharmacokinetics and fibrin specificity of alteplase during accelerated infusions in acute myocardial infarction

1 reference

12 December 2020

The pharmacokinetics of recombinant double-chain t-PA (duteplase): effects of bolus injection, infusions, and administration by weight in patients with myocardial infarction

1 reference

12 December 2020

Thrombolytic therapy: current status (1).

1 reference

12 December 2020

Pharmacokinetics and haemostatic status during consecutive infusions of recombinant tissue-type plasminogen activator in patients with acute myocardial infarction

1 reference

12 December 2020

Effects of liver blood flow on the pharmacokinetics of tissue-type plasminogen activator (alteplase) during thrombolysis in patients with acute myocardial infarction.

1 reference

12 December 2020

Coronary thrombolysis with recombinant tissue-type plasminogen activator. A hematologic and pharmacologic study

1 reference

12 December 2020

Combined tissue-type plasminogen activator and prostacyclin therapy for acute myocardial infarction. Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) 4 Study Group.

1 reference

12 December 2020

ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction)

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics of tenecteplase: results from a phase II study in patients with acute myocardial infarction.

1 reference

12 December 2020

Dose-dependent thrombolysis, pharmacokinetics and hemostatic effects of recombinant human tissue-type plasminogen activator for coronary thrombosis.

1 reference

12 December 2020

Functional effects of asparagine-linked oligosaccharide on natural and variant human tissue-type plasminogen activator

1 reference

12 December 2020

Randomized comparison of coronary thrombolysis achieved with double-bolus reteplase (recombinant plasminogen activator) and front-loaded, accelerated alteplase (recombinant tissue plasminogen activator) in patients with acute myocardial infarction.

1 reference

12 December 2020

Validation of an ELISA for the quantitation of lanoteplase, a novel plasminogen activator

1 reference

12 December 2020

A randomized dose-ranging study of rt-PA in acute myocardial infarction. Effects on coronary patency and fibrinolytic parameters

1 reference

12 December 2020

Pharmacokinetics of a slower clearing tissue plasminogen activator variant, TNK-tPA, in patients with acute myocardial infarction.

1 reference

12 December 2020

Pharmacodynamics of thrombolysis with recombinant tissue-type plasminogen activator. Correlation with characteristics of and clinical outcomes in patients with acute myocardial infarction. The TAMI Study Group

1 reference

12 December 2020

Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Fibrinolytic Therapy Trialists' (FTT) Collabo

1 reference

12 December 2020

The application of statistical moment theory to the evaluation of in vivo dissolution time and absorption time.

1 reference

12 December 2020

Thrombolytic therapy: current status (2).

1 reference

12 December 2020

Intravenous NPA for the treatment of infarcting myocardium early; InTIME-II, a double-blind comparison of single-bolus lanoteplase vs accelerated alteplase for the treatment of patients with acute myocardial infarction

1 reference

12 December 2020

Evaluation of a weight-adjusted single-bolus plasminogen activator in patients with myocardial infarction: a double-blind, randomized angiographic trial of lanoteplase versus alteplase.

1 reference

12 December 2020